Literature DB >> 6573695

A family study of HLA antigens and other genetic markers in schizophrenia.

P McGuffin, H Festenstein, R Murray.   

Abstract

HLA antigens and 19 other genetic marker systems were studied in 12 families containing 2 or more members diagnosed as schizophrenic. In contrast with previous reports we could exclude linkage between the disorder and HLA, and we found no evidence of linkage with Gm or Gc. The disagreement between our results and those of a previous study, which suggested linkage between HLA and schizophrenia, could not be explained on the basis of genetic heterogeneity within the disorder. The problems of performing a linkage study in the face of diagnostic uncertainty and an unknown mode of inheritance of the main trait are discussed, and the measures taken in attempts to overcome these difficulties are described. Despite present drawbacks, genetic marker studies hold future promise as a means of detecting major gene effects in schizophrenia and other familial psychiatric disorders.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6573695     DOI: 10.1017/s0033291700050042

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  4 in total

Review 1.  DNA and classical genetic markers in schizophrenia.

Authors:  M J Owen; P McGuffin
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270

2.  Exclusion of a schizophrenia susceptibility gene from the chromosome 5q11-q13 region: new data and a reanalysis of previous reports.

Authors:  P McGuffin; M Sargeant; G Hetti; S Tidmarsh; S Whatley; R M Marchbanks
Journal:  Am J Hum Genet       Date:  1990-09       Impact factor: 11.025

Review 3.  The molecular genetics of schizophrenia.

Authors:  K C Murphy; A G Cardno; P McGuffin
Journal:  J Mol Neurosci       Date:  1996       Impact factor: 3.444

4.  Segregation analysis of schizophrenia and related disorders.

Authors:  N Risch; M Baron
Journal:  Am J Hum Genet       Date:  1984-09       Impact factor: 11.025

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.